IntelliCell BioSciences, Inc. - OTCQB: SVFC


IntelliCell™ is pioneering a new proprietary medical process that results in acquiring Vascular Fraction Cells (VFC).

VFC is also known as stromal vascular fraction. VFC cells are known to contain significant numbers of various cell types including adult stem cells, endothelial cells, fibroblast cells, red blood cells, and much more.

VFC type cells are in research projects and in clinical trials around the world.

IntelliCell was formed to take a leading role and harmonize the interests of all the stakeholder communities in the rapidly expanding regenerative medicine field.

IntelliCell is fully committed to an ethical and supportive role in providing the tools to physicians and patients to fight some of the most serious disease conditions with very high levels of unmet clinical needs.


460 Park Ave., 17th Floor
New York, New York 10022
United States

Get Directions

Upgrade Your Listing